Alzheimer's Disease is a major cause of morbidity and mortality in aging populations and incurs a heavy toll on health services. It affects 5% of the population over 65 years and 15% over 85 years. The pathogenic pathways are not established but it is clear that the disease is etiologically heterogeneous. Using traditional reverse genetic approaches we have isolated missense mutations in the amyloid precursor protein (APP) gene which cause the illness in some early onset families. In this project we will apply reverse genetics and direct screening to separate those families (from extensive sources in the UK and US) which have APP mutations. New mutations in APP will be characterized by direct sequencing. The families which do not have APP mutations will be subject to a genome search. With the use of large pedigrees and concurrent simulation studies we will circumvent the problem of heterogeneity to genetically isolate (an) additional (locus) loci. By dissecting the genetics of Alzheimers disease in this way we will further delineate the pathogenic pathways which cause not only the pure genetic cases but the more common cases of mixed aetiology.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG011871-01
Application #
3123681
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1993-07-01
Project End
1996-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of South Florida
Department
Type
Schools of Medicine
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612
Houlden, H; Crook, R; Backhovens, H et al. (1998) ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. Am J Med Genet 81:117-21
Fox, N C; Kennedy, A M; Harvey, R J et al. (1997) Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 120 ( Pt 3):491-501
Royston, M C; Mann, D; Pickering-Brown, S et al. (1996) ApoE2 allele, Down's syndrome, and dementia. Ann N Y Acad Sci 777:255-9
Wragg, M; Hutton, M; Talbot, C (1996) Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. Alzheimer's Disease Collaborative Group. Lancet 347:509-12
Hutton, M; Busfield, F; Wragg, M et al. (1996) Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease. Neuroreport 7:801-5
Clark, R F; Hutton, M; Talbot, C et al. (1996) The role of presenilin 1 in the genetics of Alzheimer's disease. Cold Spring Harb Symp Quant Biol 61:551-8
Prihar, G; Fuldner, R A; Perez-Tur, J et al. (1996) Structure and alternative splicing of the presenilin-2 gene. Neuroreport 7:1680-4
Perez-Tur, J; Croxton, R; Wright, K et al. (1996) A further presenilin 1 mutation in the exon 8 cluster in familial Alzheimer's disease. Neurodegeneration 5:207-12
Perez-Tur, J; Froelich, S; Prihar, G et al. (1995) A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7:297-301
Lippa, C F; Smith, T W; Saunders, A M et al. (1995) Apolipoprotein E genotype and Lewy body disease. Neurology 45:97-103

Showing the most recent 10 out of 19 publications